For stable responders on established maintenance doses, extended-release formulations offer convenience advantages
The FDA has expressed concerns about compounded versions, noting they "received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products." However, many patients used compounded versions successfully under proper medical supervision.
Do not independently increase, decrease or stop a prescribed medication without appropriate medical guidance
[4] Neurophysiological studies using functional MRI and PET demonstrate that exogenous oxytocin modulates activity in the amygdala, insula, striatum, and other receptor-dense regions related to social salience and affect regulation
Concentration and mental clarity